Dr. Long is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 NW Expressway
Suite 300
Oklahoma City, OK 73112Phone+1 405-713-7040
Education & Training
- University of Utah HealthFellowship, Thoracic Surgery, 1990 - 1992
- University of Missouri-ColumbiaResidency, Surgery, 1983 - 1989
- University of Missouri-ColumbiaInternship, Internal Medicine, 1982 - 1983
- University of Missouri-Columbia School of MedicineClass of 1982
Certifications & Licensure
- OK State Medical License 2008 - 2025
- UT State Medical License 1990 - 2014
- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Clinical Trials
- REGISTRY EVALUATION OF VITAL INFORMATION FOR VADs IN AMBULATORY LIFE Start of enrollment: 2015 Jul 01
- MOMENTUM 3 IDE Clinical Study Protocol Start of enrollment: 2014 Sep 02
- The ARIES HeartMate 3 Pump IDE Study Start of enrollment: 2020 Jul 14
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 503 citationsA Fully Magnetically Levitated Circulatory Pump for Advanced Heart FailureMandeep R. Mehra, Yoshifumi Naka, Nir Uriel, Daniel J. Goldstein, Joseph C. Cleveland
The New England Journal of Medicine. 2017-02-02 - 122 citationsLong-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study.James W. Long, Abdallah G. Kfoury, Mark S. Slaughter, Marc A. Silver, Carmelo A. Milano
Congestive Heart Failure. 2005-05-01 - 179 citationsHemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure.Nir Uriel, Paolo C. Colombo, Joseph C. Cleveland, James W. Long, Christopher T. Salerno
Circulation. 2017-05-23
Press Mentions
- VADovations, Inc. Secures Investment and Development Agreement for a Percutaneous Endovascular Delivery System for Its Next-Generation Cardiac Assist Device for Long-Term UseFebruary 11th, 2020
- VADovations, Inc. Licenses Intellectual Property from Mayo Clinic to Develop a Novel Next-Generation Endovascular Cardiac Assist Device for Long-Term UseJanuary 29th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: